CUTANEOUS PLEXIFORM SCHWANNOMA ASSOCIATED WITH NEUROFIBROMATOSIS TYPE-2

被引:0
|
作者
VALBERNAL, JF [1 ]
FIGOLS, J [1 ]
VAZQUEZBARQUERO, A [1 ]
机构
[1] UNIV CANTABRIA,MARQUES VALDECILLA HOSP,FAC MED,DEPT NEUROSURG SERV,E-39008 SANTANDER,SPAIN
关键词
PERIPHERAL NERVE SHEATH TUMOR; PLEXIFORM SCHWANNOMA; NEUROFIBROMATOSIS; SCHWANNOMATOSIS; MULTIPLE CUTANEOUS SCHWANNOMAS SYNDROME; CUTANEOUS NEURAL NEOPLASM;
D O I
10.1002/1097-0142(19951001)76:7<1181::AID-CNCR2820760713>3.0.CO;2-P
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Plexiform schwannoma (PS) is a rare benign tumor of the nerve sheath that can be located either in the deep soft tissues or in the dermis or subcutis. The tumor predominantly affects young adults and occurs most commonly as a slowly growing asymptomatic solitary nodule in the head and neck region, trunk, and upper extremities. Methods. A cutaneous PS located in the preauricular region of a 19-year-old white female is reported. The patient exhibited six ''cafe-au-lait'' spots in the trunk and the extremities. Magnetic resonance imaging examination showed bilateral tumors in both acoustic nerves (considered schwannomas) and also masses in the right major sphenoidal wing, fair, and T-2-T-3 level of rachis and a solid and cystic tumor in the low medulla oblongata. Tumors of the preauricular region, medulla oblongata, spinal cord at level T-2-T-3, and major sphenoidal wing area were surgically removed. The tumors were studied by immunohistochemistry and diagnosed as PS, pilocytic astrocytoma, and meningiomas, respectively. Results, Seventy-eight cases of PS have been reported in the literature: 8 (10.2%) have been associated with clinical schwannomatosis, 6 (7.7%) with multiple cutaneous schwannomas syndrome, and only 3 (3.8%) with neurofibromatosis type 1 (NF-1). Conclusions. In this report, to the authors' knowledge, for the first time PS is described associated with neurofibromatosis type 2. The tumor does not appear to have significant association with NF-1. Plexiform schwannoma should be recognized because it may be misdiagnosed as plexiform neurofibroma or other plexiform malignant tumors. Differentiation from plexiform neurofibroma is important, because the latter is virtually pathognomonic of neurofibromatosis type 1 and has a propensity for malignant transformation.
引用
收藏
页码:1181 / 1186
页数:6
相关论文
共 50 条
  • [21] Neurofibromatosis type 2 with multiple plexiform schwannomas
    Lim, HS
    Jung, J
    Chung, KY
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (05) : 336 - 340
  • [22] THE NEUROFIBROMATOSIS TYPE-2 GENE
    MARINEAU, C
    MEREL, P
    ROULEAU, GA
    THOMAS, G
    M S-MEDECINE SCIENCES, 1995, 11 (01): : 35 - 42
  • [23] Plexiform neurofibromatosis type 1
    Sharma, Surendra K.
    Sharma, Abhishek
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 143 : 380 - 380
  • [24] Management of neurofibromatosis type 1-associated plexiform neurofibromas
    Fisher, Michael J.
    Blakeley, Jaishri O.
    Weiss, Brian D.
    Dombi, Eva
    Ahlawat, Shivani
    Akshintala, Srivandana
    Belzberg, Allan J.
    Bornhorst, Miriam
    Bredella, Miriam A.
    Cai, Wenli
    Ferner, Rosalie E.
    Gross, Andrea M.
    Harris, Gordon J.
    Listernick, Robert
    Ly, Ina
    Martin, Staci
    Mautner, Victor F.
    Salamon, Johannes M.
    Salerno, Kilian E.
    Spinner, Robert J.
    Staedtke, Verena
    Ullrich, Nicole J.
    Upadhyaya, Meena
    Wolters, Pamela L.
    Yohay, Kaleb
    Widemann, Brigitte C.
    NEURO-ONCOLOGY, 2022, 24 (11) : 1827 - 1844
  • [25] Miniature Palpebral Plexiform Neurofibroma in Neurofibromatosis Type 2
    Charles, Norman C.
    Kim, Eleanore T.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2023, 39 (06): : E186 - E188
  • [26] BENIGN PLEXIFORM (MULTINODULAR) SCHWANNOMA - A RARE TUMOR UNASSOCIATED WITH NEUROFIBROMATOSIS
    FLETCHER, CDM
    DAVIES, SE
    HISTOPATHOLOGY, 1986, 10 (09) : 971 - 980
  • [27] Plexiform schwannomata in a patient with neurofibromatosis type 2.
    Nixon, RR
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (05): : 527 - 527
  • [28] Development of drug treatments for neurofibromatosis type 2-associated vestibular schwannoma
    Blakeley, Jaishri
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2012, 20 (05): : 372 - 379
  • [29] Bevacizumab Therapy of Neurofibromatosis Type 2 Associated Vestibular Schwannoma in Japanese Patients
    Fujii, Masazumi
    Ichikawa, Masahiro
    Iwatate, Kensho
    Bakhit, Mudathir
    Yamada, Masayuki
    Kuromi, Yosuke
    Sato, Taku
    Sakuma, Jun
    Saito, Kiyoshi
    NEUROLOGIA MEDICO-CHIRURGICA, 2020, 60 (02) : 75 - 82
  • [30] RADIOLOGICAL INVESTIGATION OF NEUROFIBROMATOSIS TYPE-2
    AKESON, P
    HOLTAS, S
    NEURORADIOLOGY, 1994, 36 (02) : 107 - 110